Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Potetinova, JV; Milgotina, EI; Makarov, VA; Voyushina, TL
   Synthesis of modified peptides with C-terminal alpha-amino aldehydes
   RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
   
   J.V. Potetinova et al., "Synthesis of modified peptides with C-terminal alpha-amino aldehydes", RUS J BIOOR, 27(3), 2001, pp. 141-150
2. Bajusz, S
   Research on synthetic peptides of pharmaceutical interest at IDR
   PHARMAZIE
   
   S. Bajusz, "Research on synthetic peptides of pharmaceutical interest at IDR", PHARMAZIE, 56, 2001, pp. S4-S11
3. Clare, BW; Scozzafava, A; Briganti, F; Iorga, B; Supuran, CT
   Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: Synthesis and structure-activity correlations
   JOURNAL OF ENZYME INHIBITION
   
   B.W. Clare et al., "Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: Synthesis and structure-activity correlations", J ENZ INHIB, 15(3), 2000, pp. 235-264
4. Supuran, CT; Scozzafava, A; Briganti, F; Clare, BW
   Protease inhibitors: Synthesis and QSAR study of novel classes of nonbasicthrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at p1
   JOURNAL OF MEDICINAL CHEMISTRY
   
   C.T. Supuran et al., "Protease inhibitors: Synthesis and QSAR study of novel classes of nonbasicthrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at p1", J MED CHEM, 43(9), 2000, pp. 1793-1806
5. Melnyk, O; Fehrentz, JA; Martinez, J; Gras-Masse, H
   Functionalization of peptides and proteins by aldehyde or keto groups
   BIOPOLYMERS
   
   O. Melnyk et al., "Functionalization of peptides and proteins by aldehyde or keto groups", BIOPOLYMERS, 55(2), 2000, pp. 165-186
6. Renwinkel, JBM; Adang, AEP
   Strategies and progress towards the ideal orally active thrombin inhibitor
   CURRENT PHARMACEUTICAL DESIGN
   
   J.B.M. Renwinkel e A.E.P. Adang, "Strategies and progress towards the ideal orally active thrombin inhibitor", CUR PHARM D, 5(12), 1999, pp. 1043-1075
7. Paris, M; Pothion, C; Goulleux, L; Heitz, A; Martinez, J; Fehrentz, JA
   Synthesis of peptide aldehydes on solid support
   REACTIVE & FUNCTIONAL POLYMERS
   
   M. Paris et al., "Synthesis of peptide aldehydes on solid support", REACT FUNCT, 41(1-3), 1999, pp. 255-261
8. Agnelli, G; Sonaglia, F
   Clinical status of direct thrombin inhibitors
   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
   
   G. Agnelli e F. Sonaglia, "Clinical status of direct thrombin inhibitors", CR R ONC H, 31(2), 1999, pp. 97-117
9. Hauptmann, J; Sturzebecher, J
   Synthetic inhibitors of thrombin and factor Xa: From bench to bedside
   THROMBOSIS RESEARCH
   
   J. Hauptmann e J. Sturzebecher, "Synthetic inhibitors of thrombin and factor Xa: From bench to bedside", THROMB RES, 93(5), 1999, pp. 203-241
10. GUSTAFSSON D; ANTONSSON T; BYLUND R; ERIKSSON U; GYZANDER E; NILSSON I; ELG M; MATTSSON C; DEINUM J; PEHRSSON S; KARLSSON O; NILSSON A; SORENSEN H
    EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES
    Thrombosis and haemostasis
    
    D. Gustafsson et al., "EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES", Thrombosis and haemostasis, 79(1), 1998, pp. 110-118
11. PARIS M; HEITZ A; GUERLAVAIS V; CRISTAU M; FEHRENTZ JA; MARTINEZ J
    SYNTHESIS OF PEPTIDE ALDEHYDES ON SOLID SUPPORT USING OZONOLYSIS
    Tetrahedron letters
    
    M. Paris et al., "SYNTHESIS OF PEPTIDE ALDEHYDES ON SOLID SUPPORT USING OZONOLYSIS", Tetrahedron letters, 39(40), 1998, pp. 7287-7290
12. WILEY MR; FISHER MJ
    SMALL-MOLECULE DIRECT THROMBIN INHIBITORS
    Expert opinion on therapeutic patents
    
    M.R. Wiley e M.J. Fisher, "SMALL-MOLECULE DIRECT THROMBIN INHIBITORS", Expert opinion on therapeutic patents, 7(11), 1997, pp. 1265-1282
13. TAMURA SY; GOLDMAN EA; BRUNCK TK; RIPKA WC; SEMPLE JE
    RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY
    Bioorganic & medicinal chemistry letters
    
    S.Y. Tamura et al., "RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY", Bioorganic & medicinal chemistry letters, 7(3), 1997, pp. 331-336
14. TAMURA SY; SEMPLE JE; REINER JE; GOLDMAN EA; BRUNCK TK; LIMWILBY MS; CARPENTER SH; ROTE WE; OLDESHULTE GL; RICHARD BM; NUTT RF; RIPKA WC
    DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES
    Bioorganic & medicinal chemistry letters
    
    S.Y. Tamura et al., "DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES", Bioorganic & medicinal chemistry letters, 7(12), 1997, pp. 1543-1548
15. SEMPLE JE; ROWLEY DC; BRUNCK TK; HAUONG T; MINAMI NK; OWENS TD; TAMURA SY; GOLDMAN EA; SIEV DV; ARDECKY RJ; CARPENTER SH; GE Y; RICHARD BM; NOLAN TG; HAKANSON K; TULINSKY A; NUTT RF; RIPKA WC
    DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES
    Journal of medicinal chemistry
    
    J.E. Semple et al., "DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES", Journal of medicinal chemistry, 39(23), 1996, pp. 4531-4536
16. WALL TM; LINSEMAN DA; HARTMAN JC
    RAMIPRILAT ATTENUATES HYPOXIA REOXYGENATION INJURY TO CARDIAC MYOCYTES VIA A BRADYKININ-DEPENDENT MECHANISM/
    European journal of pharmacology
    
    T.M. Wall et al., "RAMIPRILAT ATTENUATES HYPOXIA REOXYGENATION INJURY TO CARDIAC MYOCYTES VIA A BRADYKININ-DEPENDENT MECHANISM/", European journal of pharmacology, 306(1-3), 1996, pp. 165-174
17. REERS M; KOSCHINSKY R; DICKNEITE G; HOFFMANN D; CZECH J; STUBER W
    SYNTHESIS AND CHARACTERIZATION OF NOVEL THROMBIN INHIBITORS BASED ON 4-AMIDINOPHENYLALANINE
    Journal of enzyme inhibition
    
    M. Reers et al., "SYNTHESIS AND CHARACTERIZATION OF NOVEL THROMBIN INHIBITORS BASED ON 4-AMIDINOPHENYLALANINE", Journal of enzyme inhibition, 9(1), 1995, pp. 61-72
18. CLAESON G
    SYNTHETIC PEPTIDES AND PEPTIDOMIMETICS AS SUBSTRATES AND INHIBITORS OF THROMBIN AND OTHER PROTEASES IN THE BLOOD-COAGULATION SYSTEM
    Blood coagulation & fibrinolysis
    
    G. Claeson, "SYNTHETIC PEPTIDES AND PEPTIDOMIMETICS AS SUBSTRATES AND INHIBITORS OF THROMBIN AND OTHER PROTEASES IN THE BLOOD-COAGULATION SYSTEM", Blood coagulation & fibrinolysis, 5(3), 1994, pp. 411-436
19. ADANG AEP; HERMKENS PHH; LINDERS JTM; OTTENHEIJM HCJ; VANSTAVEREN CJ
    CASE-HISTORIES OF PEPTIDOMIMETICS - PROGRESSION FROM PEPTIDES TO DRUGS
    Recueil des travaux chimiques des Pays-Bas
    
    A.E.P. Adang et al., "CASE-HISTORIES OF PEPTIDOMIMETICS - PROGRESSION FROM PEPTIDES TO DRUGS", Recueil des travaux chimiques des Pays-Bas, 113(2), 1994, pp. 63-78
20. SCHUMACHER WA; BALASUBRAMANIAN N; STLAURENT DR; SEILER SM
    EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS
    European journal of pharmacology
    
    W.A. Schumacher et al., "EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS", European journal of pharmacology, 259(2), 1994, pp. 165-171
21. TAPPARELLI C; METTERNICH R; EHRHARDT C; COOK NS
    SYNTHETIC LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS - MOLECULAR DESIGNAND PHARMACOLOGICAL PROFILE
    Trends in pharmacological sciences
    
    C. Tapparelli et al., "SYNTHETIC LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS - MOLECULAR DESIGNAND PHARMACOLOGICAL PROFILE", Trends in pharmacological sciences, 14(10), 1993, pp. 366-376